TW200616992A - Enantioselective separation method - Google Patents

Enantioselective separation method

Info

Publication number
TW200616992A
TW200616992A TW094124800A TW94124800A TW200616992A TW 200616992 A TW200616992 A TW 200616992A TW 094124800 A TW094124800 A TW 094124800A TW 94124800 A TW94124800 A TW 94124800A TW 200616992 A TW200616992 A TW 200616992A
Authority
TW
Taiwan
Prior art keywords
enantioselective
trifluoromethyl
ester
substituted
carboxylic acid
Prior art date
Application number
TW094124800A
Other languages
English (en)
Inventor
Brian P Chekal
Ernst Freund
Charles Minard Grill
Elke Huthmann
Markus Juza
Vera Leshchinskaya
Mark Thomas Maloney
Lawrence Marvin Miller Jr
Yan Wang
Ming Zeng
Original Assignee
Pharmacia & Upjohn Co Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia & Upjohn Co Llc filed Critical Pharmacia & Upjohn Co Llc
Publication of TW200616992A publication Critical patent/TW200616992A/zh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B57/00Separation of optically-active compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D15/00Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08Selective adsorption, e.g. chromatography
    • B01D15/10Selective adsorption, e.g. chromatography characterised by constructional or operational features
    • B01D15/18Selective adsorption, e.g. chromatography characterised by constructional or operational features relating to flow patterns
    • B01D15/1814Selective adsorption, e.g. chromatography characterised by constructional or operational features relating to flow patterns recycling of the fraction to be distributed
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D15/00Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08Selective adsorption, e.g. chromatography
    • B01D15/10Selective adsorption, e.g. chromatography characterised by constructional or operational features
    • B01D15/18Selective adsorption, e.g. chromatography characterised by constructional or operational features relating to flow patterns
    • B01D15/1864Selective adsorption, e.g. chromatography characterised by constructional or operational features relating to flow patterns using two or more columns
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D335/00Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
    • C07D335/04Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D335/06Benzothiopyrans; Hydrogenated benzothiopyrans
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D15/00Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08Selective adsorption, e.g. chromatography
    • B01D15/10Selective adsorption, e.g. chromatography characterised by constructional or operational features
    • B01D15/18Selective adsorption, e.g. chromatography characterised by constructional or operational features relating to flow patterns
    • B01D15/1814Selective adsorption, e.g. chromatography characterised by constructional or operational features relating to flow patterns recycling of the fraction to be distributed
    • B01D15/1857Reactive simulated moving beds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Analytical Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Sustainable Development (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrane Compounds (AREA)
TW094124800A 2004-07-23 2005-07-22 Enantioselective separation method TW200616992A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US59051604P 2004-07-23 2004-07-23

Publications (1)

Publication Number Publication Date
TW200616992A true TW200616992A (en) 2006-06-01

Family

ID=34979492

Family Applications (1)

Application Number Title Priority Date Filing Date
TW094124800A TW200616992A (en) 2004-07-23 2005-07-22 Enantioselective separation method

Country Status (9)

Country Link
US (1) US20060020022A1 (zh)
EP (1) EP1773802A1 (zh)
JP (1) JP2008507502A (zh)
AR (1) AR050179A1 (zh)
BR (1) BRPI0512251A (zh)
CA (1) CA2574363A1 (zh)
MX (1) MX2007000880A (zh)
TW (1) TW200616992A (zh)
WO (1) WO2006011047A1 (zh)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8076511B2 (en) * 2007-05-18 2011-12-13 Ampac Fine Chemicals Llc. Preparative-scale separation of enantiomers of chiral carboxylic acids
US8608967B2 (en) * 2011-03-03 2013-12-17 The Board Of Trustees Of The University Of Arkansas Multiple stationary phase matrix and uses thereof
US20130177994A1 (en) * 2012-01-05 2013-07-11 Clinical Reference Laboratory, Inc. METHODS FOR QUANTITATIVE CHIRAL DETERMINATION OF THE d- AND l- ENANTIOMERS OF AMPHETAMINE AND METHAMPHETAMINE
TWI646091B (zh) * 2012-12-28 2019-01-01 日商衛斯克慧特股份有限公司 鹽類及晶形
ES2947910T3 (es) 2019-01-22 2023-08-24 Askat Inc Proceso para la transformación asimétrica impulsada por solubilidad diferencial de ácidos 2H-cromeno-3-carboxílicos sustituidos

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5514818A (en) * 1993-09-17 1996-05-07 Daicel Chemical Industries, Ltd. Resolution of stereoisomers of aliphatic epoxides
EP0747341B1 (en) * 1994-02-25 2002-05-22 Daicel Chemical Industries, Ltd. Process for producing optically active mevalonolactone compounds
US6043271A (en) * 1994-08-03 2000-03-28 Sarawak Medichem Pharmaceuticals, Inc. Method for the preparation of (±)-calanolide A and intermediates thereof
US5892060A (en) * 1994-08-03 1999-04-06 Sarawak Medichem Pharmaceuticals, Inc. Method for the preparation of (+)-calanolide a and analogues thereof
US5977385A (en) * 1994-08-03 1999-11-02 Sarawak Medichem Pharmaceuticals Method for the preparation of (+)-calanolide A and analogues thereof
US5489697A (en) * 1994-08-03 1996-02-06 Medichem Research, Inc. Method for the preparation of (+)-calanolide A and intermediates thereof
US6277879B1 (en) * 1994-08-03 2001-08-21 Sarawak Medichem Pharmaceuticals, Inc. Calanolide analogues and methods of their use
US6458955B1 (en) * 1994-12-16 2002-10-01 Uop Llc Process for preparation of pharmaceutically desired enantiomers
US6455736B1 (en) * 1994-12-16 2002-09-24 Uop Llc Process for preparation of pharmaceutically desired sertraline and sertraline analogs
US5630943A (en) * 1995-11-30 1997-05-20 Merck Patent Gesellschaft Mit Beschrankter Haftung Discontinuous countercurrent chromatographic process and apparatus
KR100343832B1 (ko) * 1996-08-27 2002-07-20 시오노기세이야쿠가부시키가이샤 크로멘-3-카르복실산 유도체
US6130353A (en) * 1997-03-18 2000-10-10 Chiral Technologies, Inc. Chiral separations of amino acids
US6077850A (en) * 1997-04-21 2000-06-20 G.D. Searle & Co. Substituted benzopyran analogs for the treatment of inflammation
US6063284A (en) * 1997-05-15 2000-05-16 Em Industries, Inc. Single column closed-loop recycling with periodic intra-profile injection
US5928515A (en) * 1997-12-12 1999-07-27 Uop Llc Adsorptive separation of 3-hydroxytetrahydrofuran enantiomers
US6107492A (en) * 1998-05-08 2000-08-22 Ucb, S.A. Process for the preparation of levetiracetam
AU1705400A (en) * 1998-10-15 2000-05-01 Sarawak Medichem Pharmaceuticals, Inc. Method and composition for treating and preventing tuberculosis
US20020103141A1 (en) * 1998-12-23 2002-08-01 Mckearn John P. Antiangiogenic combination therapy for the treatment of cancer
JP4350946B2 (ja) * 2000-10-31 2009-10-28 メルク エンド カムパニー インコーポレーテッド 糖尿病及び脂質異常症の治療のためのベンゾピランカルボン酸誘導体
US7339062B2 (en) * 2002-09-20 2008-03-04 Nissan Chemical Industries, Ltd. Method for producing a 3,5-dihydroxy-6-heptenoate
US20050148627A1 (en) * 2003-03-31 2005-07-07 Jeffery Carter Benzopyran compounds for use in the treatment and prevention of inflammation related conditions
US7259266B2 (en) * 2003-03-31 2007-08-21 Pharmacia Corporation Benzopyran compounds useful for treating inflammatory conditions

Also Published As

Publication number Publication date
BRPI0512251A (pt) 2008-02-19
JP2008507502A (ja) 2008-03-13
WO2006011047A1 (en) 2006-02-02
MX2007000880A (es) 2007-03-12
US20060020022A1 (en) 2006-01-26
EP1773802A1 (en) 2007-04-18
CA2574363A1 (en) 2006-02-02
AR050179A1 (es) 2006-10-04

Similar Documents

Publication Publication Date Title
WO2009031680A1 (ja) 1,3-ジ飽和-2-不飽和トリグリセリドの分別方法
NZ623602A (en) N-[(2’r)-2’-deoxy-2’-fluoro-2’-methyl-p-phenyl-5’-uridylyl]-l-alanine 1-methylethyl ester and process for its production
DK1713458T3 (da) Fremgangsmåde til forstærkning af biotilgængeligheden af ospemifen
WO2006016178A8 (en) Enantioselective process
TW200616992A (en) Enantioselective separation method
MY139978A (en) Methods for producing alkyl esters
WO2010010298A3 (fr) Procede de fabrication d'acide propionique bio-ressource a partir de glycerol
DE602005011463D1 (de) Verfahren zur abtrennung von modafinil
WO2008084472A3 (en) Improved process for the preparation of oxidized phospholipids
WO2006004977A3 (en) Process for the optical resolution and recycling of tomoxetine
WO2006006161A3 (en) Improved process for the preparation of oxidized phospholipids
WO2011087316A3 (ko) 테트라졸 메탄설폰산 염의 제조방법 및 이에 사용되는 신규 화합물
HRP20240146T1 (hr) Postupci dobivanja i upotrebe inhibitora pde9
IL223126A0 (en) Method for the preparation of acetic 4,5-diacetoxy-tetrahydro-furan-2-ylmethyl ester as well as its stereo isomers
MX2009005664A (es) D-isoglutamil-d-triptofano cristalino, y la sal monoamonica de d-isoglutamil-d-triptofano.
WO2008107887A3 (en) (1r,1'r)-atracurium salts separation process
WO2008092939A3 (en) Process for the preparation of optically pure omeprazole via salt formation with a chiral amine or treatment with an entiomer converting enzyme and chromatographic separation
AU2003241211A1 (en) Method for the recovery of ferulic acid
DK1644469T3 (da) Fremgangsmåde til fremstilling af oprensede fedtsyrer
WO2007023129A3 (de) Verfahren zur trennung verbindungsbildender chiraler systeme
WO2016098123A3 (en) A recycling process for preparing (s)-2-[(substituted-phenoxy)-phenoxy- phosphorylamino] propionic acid isopropyl ester diastereomers
AU2003299300A1 (en) METHOD FOR THE PRODUCTION OF R-Alpha-LIPOIC ACID BY FERMENTATION
ZA200409433B (en) Process for the preparation of carboxylic acid esters.
TW200609233A (en) Racemization method
WO2007077118A3 (de) Racematspaltung von 2,6-trans-dimethylmorpholin